These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 4120896)
41. Prolongation of rat cardiac allograft survival by a new immunosuppressant: chicken anti-rat lymphocyte globulin. Morris RE; Souther SG; Dong E; Vistnes LM; Shumway NE Surgery; 1974 Jul; 76(1):150-9. PubMed ID: 4601599 [No Abstract] [Full Text] [Related]
42. Complement-activating properties of some rat alloantibodies. Ruszkiewicz M Transplantation; 1975 Sep; 20(3):227-36. PubMed ID: 1080612 [TBL] [Abstract][Full Text] [Related]
43. Selective lymphoid irradiation. V. Synergism with pretransplant thymectomy or thymic irradiation in cardiac transplantation in rats. Iga C; Fawwaz R; Nowygrod R; Reemtsma K; Hardy MA Transplantation; 1985 Mar; 39(3):232-6. PubMed ID: 3883585 [TBL] [Abstract][Full Text] [Related]
44. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031 [TBL] [Abstract][Full Text] [Related]
45. In Contrast to Anti-C5 Therapy, Cobra Venom Factor Does Not Prevent Rejection of Xenogeneic Cartilage in Mice. Brokaw JL; Costa C Transplant Proc; 2015 Oct; 47(8):2397-9. PubMed ID: 26518939 [TBL] [Abstract][Full Text] [Related]
46. Humoral immune responses during acute rejection in rat lung transplantation. Yamane M; Sano Y; Nagahiro I; Aoe M; Date H; Ando A; Shimizu N Transpl Immunol; 2003; 11(1):31-7. PubMed ID: 12727473 [TBL] [Abstract][Full Text] [Related]
47. The differential destructive and enhancing effects of anti-H-2K, H-2D, and anti-Ia antisera on murine skin allografts. McKenzie IF; Henning MM J Exp Med; 1978 Feb; 147(2):611-6. PubMed ID: 342669 [TBL] [Abstract][Full Text] [Related]
48. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection. Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803 [TBL] [Abstract][Full Text] [Related]
49. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO. WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948 [TBL] [Abstract][Full Text] [Related]
50. Survival of cardiac xenografts. Effect of antithymocyte serum and enhancing heteroantiserum. Corry RJ; Kelley SE Arch Surg; 1975 Sep; 110(9):1143-5. PubMed ID: 1098620 [TBL] [Abstract][Full Text] [Related]
52. Evidence for the involvement of the Ss protein of the mouse in the hemolytic complement system. Hansen TH; Shin HS; Shreffler DC J Exp Med; 1975 May; 141(5):1216-20. PubMed ID: 805206 [TBL] [Abstract][Full Text] [Related]
53. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450 [TBL] [Abstract][Full Text] [Related]
54. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy. Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S Transplant Proc; 2006 Dec; 38(10):3263-5. PubMed ID: 17175243 [TBL] [Abstract][Full Text] [Related]
55. Dissociation of lymphocyte activation and graft-versus-host competence of blood cells after skin grafting in rats treated with antithymocyte and normal pig serum. Hasková V; Korcáková L; Bednarík T Transplantation; 1973 Oct; 16(4):325-30. PubMed ID: 4147638 [No Abstract] [Full Text] [Related]
56. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake. Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259 [TBL] [Abstract][Full Text] [Related]
57. Passive enhancement and hyperacute rejection of renal allografts in the rat. Winearls CG; Fabre JW; Hart DN; Millard PR; Morris PJ Transplantation; 1980 Jun; 29(6):462-7. PubMed ID: 6996236 [TBL] [Abstract][Full Text] [Related]
58. Transfer of tubulointerstitial nephritis in the Brown Norway rat with anti-tubular basement membrane antibody: quantitation and kinetics of binding and effect of decomplementation. Bannister KM; Wilson CB J Immunol; 1985 Dec; 135(6):3911-7. PubMed ID: 3877759 [TBL] [Abstract][Full Text] [Related]
59. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement. Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278 [TBL] [Abstract][Full Text] [Related]
60. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]